Published in Arthritis Rheum on February 01, 1991
Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med (1996) 3.60
Acquired immunodeficiency syndrome in New York City. Evaluation of an active surveillance system. JAMA (1985) 3.45
Laparoscopic inguinal herniorrhaphy. Results of a multicenter trial. Ann Surg (1995) 3.28
Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med (1991) 3.14
Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol (2012) 2.96
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology (1996) 2.47
Inflammation and liver cancer: new molecular links . Ann N Y Acad Sci (2009) 2.29
Methylotrophic Methylobacterium bacteria nodulate and fix nitrogen in symbiosis with legumes. J Bacteriol (2001) 2.25
Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis. Hepatology (2000) 2.24
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol (2000) 2.22
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev (2010) 2.09
New therapies for hepatocellular carcinoma. Oncogene (2006) 2.05
Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology (1993) 1.95
Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut (2000) 1.82
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med (2001) 1.80
Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents. J Hepatol (2000) 1.73
Accidental ingestion and aspiration of root canal instruments and other dental foreign bodies in a French population. Int Endod J (2007) 1.68
Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. Hepatology (1998) 1.67
Bilateral inguinal hernia repair: laparoscopic or open approach? Hernia (2010) 1.64
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
The problem of aging human remains and living individuals: a review. Forensic Sci Int (2009) 1.59
Electrostatic force microscopy on oriented graphite surfaces: coexistence of insulating and conducting behaviors. Phys Rev Lett (2006) 1.58
Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma. Hepatology (2001) 1.56
Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology (1996) 1.56
Liver transplantation in cirrhotic patients with diabetes mellitus: midterm results, survival, and adverse events. Liver Transpl (2001) 1.44
Magnesium binding to the bacterial chemotaxis protein CheY results in large conformational changes involving its functional surface. J Mol Biol (1994) 1.44
Biodentine(TM) induces TGF-β1 release from human pulp cells and early dental pulp mineralization. Int Endod J (2011) 1.42
Determinants of plasma homocyst(e)ine in patients with nephrotic syndrome. J Mol Med (Berl) (2000) 1.42
Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr Gene Ther (2003) 1.42
Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction. Atherosclerosis (1998) 1.42
Rituximab in CD20 positive multiple myeloma. Leukemia (2007) 1.40
[Attempted suicide with isoniazid]. Med Clin (Barc) (1992) 1.38
Liver transplantation in cirrhotic patients over 60 years of age. Rev Esp Enferm Dig (1998) 1.38
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model. Antimicrob Agents Chemother (2002) 1.32
Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology (1994) 1.32
Human dentin production in vitro. Exp Cell Res (2000) 1.26
Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology (1997) 1.25
Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon. J Hepatol (1994) 1.25
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl (2001) 1.25
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology (1987) 1.23
Lack of correlation among three methods for evaluation of apical leakage. J Endod (2001) 1.22
Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology (1989) 1.20
Leukocyte-cell adhesion: a molecular process fundamental in leukocyte physiology. Immunol Rev (1990) 1.18
Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin-resistant epidemic clones. Antimicrob Agents Chemother (2001) 1.18
Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J Immunol (2000) 1.17
MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene (2012) 1.17
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol (2010) 1.15
Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J Hepatol (1996) 1.15
Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. Oncogene (2008) 1.15
Transmission of hepatitis C virus infection to tree shrews. Virology (1998) 1.14
Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct. Cell Immunol (1992) 1.12
Acute intoxication due to topical application of diethylene glycol. Ann Intern Med (1987) 1.10
Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology (1992) 1.10
Quality of life in breast cancer survivors as identified by focus groups. Psychooncology (1997) 1.09
Amphiregulin: a new growth factor in hepatocarcinogenesis. Cancer Lett (2007) 1.08
In vitro apical leakage of system B compared with other filling techniques. J Endod (2001) 1.08
Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment. J Hepatol (1998) 1.07
Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol (2001) 1.07
Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety. Am J Transplant (2013) 1.07
Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease. Clin Chem (1994) 1.06
Identification of a novel adhesion molecule in human leukocytes by monoclonal antibody LB-2. FEBS Lett (1987) 1.05
Quality of life in breast cancer. Part II: Psychological and spiritual well-being. Cancer Nurs (1998) 1.05
Quality of life in breast cancer. Cancer Pract (1997) 1.05
Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology (1993) 1.05
Liver cytoprotection by prostaglandins. Pharmacol Ther (1993) 1.05
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology (2001) 1.04
Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology (1995) 1.03
The expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol (1991) 1.02
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma. Cancer Gene Ther (2010) 1.02
Plant lock and ant key: pairwise coevolution of an exclusion filter in an ant-plant mutualism. Proc Biol Sci (2001) 1.02
Thermodynamic analysis of the chemotactic protein from Escherichia coli, CheY. Biochemistry (1993) 1.02
Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats. Gut (2006) 1.02
A two-rooted maxillary central incisor with a normal clinical crown. J Endod (1993) 1.01
Activity of fluconazole: postantifungal effect, effects of low concentrations and of pretreatment on the susceptibility of Candida albicans to leucocytes. J Antimicrob Chemother (1994) 1.01
Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity. Eur J Immunol (2001) 1.01
The response of the hepatocyte to ischemia. Liver Int (2007) 1.01
Effects of pressure and measurement time on the fluid filtration method in endodontics. J Endod (2001) 1.01
PET findings and neuropsychological deficits in a case of Fahr's disease. Psychiatry Res (2001) 1.00
Polarity of immunogens: implications for vaccine design. Eur J Immunol (1990) 1.00
Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice. Gut (2004) 1.00
Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. Gastroenterology (1997) 1.00
In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. J Antimicrob Chemother (2007) 1.00
Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology (1997) 0.99
Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol (1997) 0.99
Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers. Antimicrob Agents Chemother (1996) 0.99
N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. J Interferon Res (1993) 0.99
Quantitative evaluation by glucose diffusion of microleakage in aged calcium silicate-based open-sandwich restorations. Int J Dent (2011) 0.98